Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
2.3700+0.0700 (+3.04%)
As of 01:19PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
12,240
9,679
859.781
2,942
6,645
Selling general and administrative
5,639
8,887
1,270
3,015
7,544
Total operating expenses
18,038
18,678
2,246
6,159
14,315
Operating income or loss
-18,038
-18,678
-2,246
-6,159
-14,315
Interest expense
1,365
1,297
1,882
1,464
142.173
Total other income/expenses net
250.307
-3,461
116.761
369.698
-377.224
Income before tax
-18,952
-23,370
-4,011
-7,241
-14,833
Income from continuing operations
-18,952
-23,370
-4,011
-7,241
-14,833
Net income
-18,473
-22,990
-3,997
-7,176
-13,232
Net income available to common shareholders
-18,473
-22,990
-3,997
-7,176
-13,232
Basic EPS
-
-1.88
-0.31
-0.56
-1.03
Diluted EPS
-
-1.88
-0.31
-0.56
-1.03
Basic average shares
-
12,406
12,865
12,865
12,865
Diluted average shares
-
12,406
12,865
12,865
12,865
EBITDA
-
-21,961
-2,012
-5,575
-14,565